Wes Streeting has suggested that no-show patients may be fined in the future because NHS lost £1 billion to nearly eight million missed NHS appointments in the last year.

The government has been urged to prioritize funding and fast-track the implementation of the National Community Health ...

Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after ...

Initiatives aimed at getting homeless people healthier and off the streets are running up against new, aggressive crackdowns.

Eli Lilly's treatment for early Alzheimer's was deemed too expensive for wide use by UK's cost-effectiveness body on ...

As senior national health leaders, we have seen firsthand the devastation of health crises unaddressed. The coronavirus pandemic, one of the greatest public health challenges in modern history, cost ...

For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its ...

CON, ophthalmologist, ophthalmology, healthcare, hospitals, industries, law, Jay Singleton, Institute For Justice ...

Travel difficulties, communication issues and stress are stopping patients across the U.K. from attending their hospital ...

The U.S. drug overdose epidemic is a “clear and present public health, public safety, and national security threat." ...

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...

The UK Government has recommended offering a COVID-19 booster vaccination in autumn, 2024, to individuals at high risk of ...